Daniel Grima from Cornerstone Research in Canada brought this news link to my attention. According to the numbers presented in the article, we are in for a very bumpy ride. The Wall Street Journal estimated that generics will be taken out $67 billion annual U.S. sales from the top pharmaceutical companies over the time frame 2007 to 2012. The alarming piece of news is that these $67 billion represent 50% of the total U.S. sales of those companies.
No comments:
Post a Comment